Management is re-underwriting a specific asset or business at a value far above its cost, using fresh third-party marks
The model's full reasoning — Q1 2018 call → NOThe question asks whether management puts a concrete, externally-derived value on something the company already owns or controls, and conveys that this value is far above what the company paid, carries it at, or what the company's current results would imply. Looking through the transcript, management discusses: - Revenue growth, consumables, instruments - NovaSeq, NextSeq, iSeq - Microarray business growth - Partnerships with Loxo Oncology and BMS - Helix investment and tax benefit - Various clinical programs The Helix discussion: "there was a tax benefit to Illumina following our participation in the recent Series B financing round. As a result of our first cash investment, we recognized a one-time 12.7 million or $0.09 per share tax benefit for prior year Helix losses." This is about a tax benefit from recognizing prior losses, not about valuing an asset at market above cost. The partnerships with Loxo and BMS are forward-looking collaborations, not valuations of existing holdings. The microarray business is discussed in terms of growth, not valuation. There's no discussion of valuing a specific asset, stake, division, or holding against an outside reference point (like a third-party offer, comparable transaction, public market value of a stake, etc.). Management discusses operating results, growth, margins, outlook - but no specific asset is being re-underwritten at market using third-party evidence. The answer is NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| TTI | TETRA Technologies, Inc. | Q1 2024 | 2024-05-01 | A |
| MNKD | MannKind Corporation | Q4 2023 | 2024-02-27 | C |
| GPRE | Green Plains Inc. | Q4 2023 | 2024-02-07 | F |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| IRBT | iRobot Corporation | Q3 2021 | 2021-10-28 | D |
TTI · Q1 2024 → YESThe question is: Does management put a CONCRETE, EXTERNALLY-DERIVED VALUE ON SOMETHING THE COMPANY ALREADY OWNS OR CONTROLS, and convey that this value is far above what the company paid, carries it a...YES Management identifies a specific asset: its holdings in Standard Lithium and Kodiak Gas Services (marketable securities worth slightly over $13 million, with total marketable securities around $30 million). It grounds the value in an external reference—the recent Kodiak acquisition of CSI Compressco, which made the stake “very favorable to TETRA,” plus Kodiak’s $2.5 billion market cap and strong trading volumes that allow quick, low-pressure monetization.
GPRE · Q4 2023 → YESThe question is: Does management put a CONCRETE, EXTERNALLY-DERIVED VALUE ON SOMETHING THE COMPANY ALREADY OWNS OR CONTROLS, and convey that this value is far above what the company paid, carries it a...YES Todd Becker explicitly identifies the company's ethanol plants as the specific asset being valued. He states that a high-quality plant trades in the private market at $1.80–$2.00 per gallon (or $2–$2.50 to build from scratch), while the company's overall market cap and net debt imply a lower value for its ~950 million gallon capacity.
AFL · Q2 2023 → YESThe question is: Does management put a CONCRETE, EXTERNALLY-DERIVED VALUE ON SOMETHING THE COMPANY ALREADY OWNS OR CONTROLS, and convey that this value is far above what the company paid, carries it a...YES Management identifies the specific equity stake in Varagon Capital (a minority interest they already held) and grounds its value in the external transaction where Man Group is acquiring Varagon.